Derek Asay
Senior Vice-President, Lilly Value and Access, Eli Lilly and Company
Derek Asay is Senior Vice President, Government Strategy and Federal Accounts at Lilly USA. His team is responsible for Lilly business strategy across all government segments, including Medicare, Medicaid, and 340B. Derek leads the ongoing Lilly relationship with Centers for Medicare and Medicaid Services (CMS) across all Medicare and Medicaid business. He leads the strategy and implementation of all health care and drug pricing reform legislation and regulations from the Lilly business perspective. Derek regularly engages with policymakers as well as the leadership of large payers and health systems on healthcare policy and drug pricing issues. For the past two plus years, Derek has also led Lilly’s COVID-19 monoclonal antibody (mAb) treatment business in the U.S. His team also leads Lilly’s healthcare transformation and policy partnership efforts. Prior to his current role, Derek held leadership positions in payer marketing since joining Lilly in 1999.Derek holds an undergraduate degree in Economics and Political Science from Indiana University and a Master’s in Business Administration in Finance and Marketing from the Leonard N. Stern School of Business at New York University.
